Human hepatocyte PNPLA3 148M exacerbates rapid non-alcoholic steatohepatitis development in chimeric mice
Kabbani, M.; Michailidis, E.; Steensels, S.; Fulmer, C. G.; Luna, J. M.; Le Pen, J.; Tardelli, M.; Razooky, B.; Ricardo-Lax, I.; Zou, C.; Zeck, B.; Stenzel, A. F.; Quirk, C.; Foquet, L.; Ashbrook, A. W.; Schneider, W. M.; Belkaya, S.; Lalazar, G.; Liang, Y.; Pittman, M.; Devisscher, L.; Suemizu, H.; Theise, N. D.; Chiriboga, L.; Cohen, D. E.; Copenhaver, R.; Grompe, M.; Meuleman, P.; Ersoy, B. A.; Rice, C. M.; de Jong, Y. P.
Show abstract
Advanced non-alcoholic fatty liver disease (NAFLD) is a rapidly emerging global health problem associated with pre-disposing genetic polymorphisms, most strikingly an isoleucine to methionine substitution in patatin-like phospholipase domain-containing protein 3 (PNPLA3-I148M). Here, we study how human hepatocytes with PNPLA3 148I and 148M variants engrafted in the livers of chimeric mice respond to a hypercaloric Western-style diet. As early as 4 weeks, mice developed dyslipidemia, impaired glucose tolerance, and steatohepatitis selectively in the human graft, followed by pericellular fibrosis after 8 weeks of hypercaloric feeding. The PNPLA3 148M variant, either from a homozygous 148M human donor or overexpressed in a homozygous 148I donor background, caused widespread microvesicular steatosis and even more severe steatohepatitis. We conclude that PNPLA3 148M in human hepatocytes exacerbates NAFLD. These models will facilitate mechanistic studies into human genetic variants associated with advanced fatty liver diseases.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Autocrine IL11 cis-signaling in hepatocytes is an initiating nexus between lipotoxicity and non-alcoholic steatohepatitis 96%
- A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated lipoprotein re-uptake 95%
- Lysates of Methylococcus capsulatus Bath induce a lean-like microbiota, intestinal FoxP3+RORγt+IL-17+ Tregs and improve metabolism 95%
Similar papers in this journal
- iPSC-derived hepatocytes from patients with nonalcoholic fatty liver disease display a disease-specific gene expression profile 94%
- Systemic identification of functionally conserved lncRNA metabolic regulators in human and mouse livers 94%
- Impaired redox and protein homeostasis as risk factors and therapeutic targets in toxin-induced biliary atresia 93%
Similar papers in this journal
- Hepatic lipopolysaccharide binding protein partially uncouples inflammation from fibrosis in MAFLD 95%
- The human glucocorticoid receptor variant rs6190 promotes blood cholesterol and atherosclerosis 93%
- Liver-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice 93%
Similar papers in this journal
- IGFBP2 expressing midlobular hepatocytes preferentially contribute to liver homeostasis and regeneration 94%
- VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis 93%
- Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.